Related Experiment Video

Updated: Jun 22, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Inhibiting gastric cancer-associated angiogenesis by CIAPIN1 siRNA

Kun Yan1, Li-Jie He, Wei Cheng

  • 1Department of General Surgery, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.

Cancer Biology & Therapy
|June 9, 2009
PubMed

Insights

Selective inhibition of CIAPIN1 (Cellular inhibitor of apoptosis protein 1) significantly suppressed gastric cancer growth and angiogenesis. This targeted approach offers a promising strategy for improving cancer therapy by disrupting tumor development and spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Angiogenesis is crucial for tumor growth and metastasis, making it a key therapeutic target in cancer treatment.
  • Cellular inhibitor of apoptosis protein 1 (CIAPIN1) has been implicated in tumor progression and multidrug resistance.

Purpose of the Study:

  • To investigate the effects of selective CIAPIN1 inhibition on angiogenesis in the SGC7901 gastric cancer cell line.
  • To evaluate the role of CIAPIN1 in gastric cancer cell growth, migration, and the formation of new blood vessels.

Main Methods:

  • Stable transfection of SGC7901 gastric cancer cells with CIAPIN1 siRNA (small interfering RNA).
  • Assessment of in vitro endothelial cell proliferation, migration, and tube formation using conditioned media from treated cells.
  • Evaluation of in vivo tumorigenicity and angiogenesis in a model system.

Main Results:

  • Conditioned media from CIAPIN1 siRNA-treated cells significantly suppressed human umbilical vein endothelial cell proliferation, migration, and tube formation.
  • Stable transfection with CIAPIN1 siRNA demonstrated inhibition of in vivo tumor growth and angiogenesis.
  • CIAPIN1 was confirmed to play a determined role in tumor growth and multidrug resistance.

Conclusions:

  • Selective inhibition of CIAPIN1 effectively suppresses gastric cancer-associated angiogenesis.
  • Targeting CIAPIN1 represents a promising therapeutic strategy for gastric cancer, impacting both tumor growth and the tumor microenvironment.

More Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...